Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig

Purpose. To confirm its dose-dependent effect on form deprivation myopia and evaluate the effect of MT3 at different tissue concentrations on changes in mRNA and protein expression for TGF-β2 and HAS2. Methods. MT3 was intravitreally injected into deprived eyes at two-day intervals. Refraction was m...

Full description

Saved in:
Bibliographic Details
Main Authors: Tao Li, Xiaodong Zhou, Bing Li, Bo Jiang
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2017/5028019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849412461759823872
author Tao Li
Xiaodong Zhou
Bing Li
Bo Jiang
author_facet Tao Li
Xiaodong Zhou
Bing Li
Bo Jiang
author_sort Tao Li
collection DOAJ
description Purpose. To confirm its dose-dependent effect on form deprivation myopia and evaluate the effect of MT3 at different tissue concentrations on changes in mRNA and protein expression for TGF-β2 and HAS2. Methods. MT3 was intravitreally injected into deprived eyes at two-day intervals. Refraction was measured by streak retinoscopy after cycloplegia. The axial dimensions were measured by A-scan ultrasound. The quantitative RT-PCR and Western blot were used to detect the changes of TGF-β2 and HAS2 expressions in the retina and choroid of guinea pigs. Results. MT3 treatment produced a significant dose-dependent reduction in relative myopia compared to FD group (both p<0.001). There were statistically significant increases in retinal and choroidal mRNA levels for both TGF-β2 and HAS2 after injections of 10 μM of MT3, when compared to the FD group. There were no significant differences in retinal and choroidal TGF-β2 protein expression levels between the MT3 treatment groups and FD group (all p>0.05). The injections of 10 μM of MT3 caused a marked decrease in retinal HAS2 protein expression level, when compared to the FD group (p=0.001). Conclusion. MT3 can inhibit form deprivation myopia, and MT3 treatment can result in changes of retinal and choroidal TGF-β2 and HAS2 mRNA and protein expressions.
format Article
id doaj-art-59ce886c87294f2ab89d8eff0aace790
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-59ce886c87294f2ab89d8eff0aace7902025-08-20T03:34:26ZengWileyJournal of Ophthalmology2090-004X2090-00582017-01-01201710.1155/2017/50280195028019Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea PigTao Li0Xiaodong Zhou1Bing Li2Bo Jiang3Department of Ophthalmology, Jinshan Hospital of Fudan University, Shanghai, ChinaDepartment of Ophthalmology, Jinshan Hospital of Fudan University, Shanghai, ChinaDepartment of Central Laboratory, Jinshan Hospital of Fudan University, Shanghai, ChinaDepartment of Ophthalmology, Jinshan Hospital of Fudan University, Shanghai, ChinaPurpose. To confirm its dose-dependent effect on form deprivation myopia and evaluate the effect of MT3 at different tissue concentrations on changes in mRNA and protein expression for TGF-β2 and HAS2. Methods. MT3 was intravitreally injected into deprived eyes at two-day intervals. Refraction was measured by streak retinoscopy after cycloplegia. The axial dimensions were measured by A-scan ultrasound. The quantitative RT-PCR and Western blot were used to detect the changes of TGF-β2 and HAS2 expressions in the retina and choroid of guinea pigs. Results. MT3 treatment produced a significant dose-dependent reduction in relative myopia compared to FD group (both p<0.001). There were statistically significant increases in retinal and choroidal mRNA levels for both TGF-β2 and HAS2 after injections of 10 μM of MT3, when compared to the FD group. There were no significant differences in retinal and choroidal TGF-β2 protein expression levels between the MT3 treatment groups and FD group (all p>0.05). The injections of 10 μM of MT3 caused a marked decrease in retinal HAS2 protein expression level, when compared to the FD group (p=0.001). Conclusion. MT3 can inhibit form deprivation myopia, and MT3 treatment can result in changes of retinal and choroidal TGF-β2 and HAS2 mRNA and protein expressions.http://dx.doi.org/10.1155/2017/5028019
spellingShingle Tao Li
Xiaodong Zhou
Bing Li
Bo Jiang
Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
Journal of Ophthalmology
title Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
title_full Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
title_fullStr Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
title_full_unstemmed Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
title_short Effect of MT3 on Retinal and Choroidal TGF-β2 and HAS2 Expressions in Form Deprivation Myopia of Guinea Pig
title_sort effect of mt3 on retinal and choroidal tgf β2 and has2 expressions in form deprivation myopia of guinea pig
url http://dx.doi.org/10.1155/2017/5028019
work_keys_str_mv AT taoli effectofmt3onretinalandchoroidaltgfb2andhas2expressionsinformdeprivationmyopiaofguineapig
AT xiaodongzhou effectofmt3onretinalandchoroidaltgfb2andhas2expressionsinformdeprivationmyopiaofguineapig
AT bingli effectofmt3onretinalandchoroidaltgfb2andhas2expressionsinformdeprivationmyopiaofguineapig
AT bojiang effectofmt3onretinalandchoroidaltgfb2andhas2expressionsinformdeprivationmyopiaofguineapig